MedtronicXSWX:MDT +1.21%21 FCF Yield % is 5.29 as of Jun. 25, 2026, which is 27% above its 10-year median of 4.18. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Medtronic ranks better than 82.69% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Medtronic's FCF Yield % or its related term are showing as below:
XSWX:MDT'
s FCF Yield % Range Over the Past 10 Years
Min: 2.6 Med: 4.18 Max: 6.36
Current: 5.29
During the past 13 years, the highest FCF Yield % of Medtronic was 6.36%. The lowest was 2.60%. And the median was 4.18%.
XSWX:MDT's FCF Yield % is ranked better than 82.69% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.37
vs XSWX:MDT: 5.29
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Medtronic FCF Yield % Related Terms
Medtronic FCF Yield % Historical Data
* Premium members only.
The historical data trend for Medtronic's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medtronic's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Medtronic's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medtronic (XSWX:MDT) has a FCF Yield % of 5.29 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medtronic and its competitors. This is 27% above median its historical median of 4.18. Over the past decade, Medtronic's FCF Yield % has ranged from 2.60 to 6.36. According to the industry distribution chart, Medtronic ranks #148 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 17.3%.
Is Medtronic's FCF Yield % too high?
Medtronic's current FCF Yield % of 5.29 is 27% above median its 10-year median of 4.18. Over the past 10 years, this metric has ranged from a low of 2.60 to a high of 6.36. Based on the distribution chart, Medtronic ranks #148 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's FCF Yield % compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #148 out of 855 companies for FCF Yield %. This places Medtronic in the top 17% of its industry — outperforming the majority of peers. Historically, Medtronic's own FCF Yield % has ranged from 2.60 to 6.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Medtronic and its competitors. Medtronic's current FCF Yield % is 5.29, which is 27% above median its own 10-year median of 4.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current FCF Yield % is 5.29, which is 27% above median its 10-year median of 4.18. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current FCF Yield % is 5.29 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtronic (XSWX:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, Medtronic stock appears to be undervalued.
The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97.
GuruFocus considers Medtronic to be Modestly Undervalued.
Key valuation signals for XSWX:MDT:
FCF Yield %: 5.29 (27% above median its 10-year median of 4.18)
GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score
Get the complete analysis for XSWX:MDT
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MDT has been successfully added to your 
